Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population

The role of complement factor C3 in lipid metabolism

(2015) Andreea Barbu et al.   MOLECULAR IMMUNOLOGY

Association between Complement C3 and Prevalence of Fatty Liver Disease in an Adult Population: A Cross-Sectional Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study

(2015) Qiyu Jia et al.   PLoS One

Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects

(2014) Nam Hoon Kim et al.   LIVER INTERNATIONAL

The complement system in human cardiometabolic disease

(2014) E. Hertle et al.   MOLECULAR IMMUNOLOGY

Non-alcoholic fatty liver disease

(2014) N. Sattar et al.   BMJ-British Medical Journal

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools

(2014) Rosaria Meli et al.   Frontiers in Immunology

Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study

(2013) Chengfu Xu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study

(2013) Nick Wlazlo et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study

(2012) Teruki Miyake et al.   JOURNAL OF GASTROENTEROLOGY

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

(2012) Zobair M. Younossi et al.   MEDICINE

Complement C3 and cleavage products in cardiometabolic risk

(2011) Altan Onat et al.   CLINICA CHIMICA ACTA

Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease

(2011) Chaohui Yu et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

(2010) Brad Q. Starley et al.   HEPATOLOGY

Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study)

(2010) Marleen M.J. van Greevenbroek et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010

(2010) Jian Gao FAN et al.   Journal of Digestive Diseases

Pathology of nonalcoholic fatty liver disease

(2010) Elizabeth M. Brunt   Nature Reviews Gastroenterology & Hepatology

Activation of the complement system in human nonalcoholic fatty liver disease

(2009) Sander S. Rensen et al.   HEPATOLOGY

Predictive Factors for the Development or Regression of Fatty Liver in Japanese Adults

(2009) Katsuhisa Omagari et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

(2008) Harmeet Malhi et al.   SEMINARS IN LIVER DISEASE